This table was developed under the Making Medical Injections Safer project, which PATH partners on in the areas of health care waste management (HCWM) and procurement technical assistance. The table provides brief summaries and contact information on many of the organizations that are actively engaged in HCWM throughout the developing world. It is intended to be a resource for country programs and governments seeking funding to support HCWM activities at the country level.

Publication date: June 2009

Region: Global

This document is intended to start discussions around quantifying the need for safe injection equipment and the amount of infectious sharps waste produced by testing and treatment programs for diseases such as HIV/AIDS, tuberculosis, and malaria. The analysis was developed to support advocacy efforts to integrate injection safety as an essential element of all health care programs.

Publication date: June 2009

Region: Global

Target specifications for an anemia diagnostic were determined by surveying personnel in nutritional programs, and methods and analytes were derived from a literature review. Presented at: Second International Micronutrient Forum, Bejing, China.

Author: Crudder C, Metzler M, Garrett D, Boyle DS, Levin C

Publication date: May 2009

Region: Global

This special issue of Directions in Global Health highlights PATH’s work to advance technologies to improve global health. Featured technologies include low-cost tests to screen for cervical cancer, a new vaccine to protect against meningitis in Africa, products to prevent diarrheal disease, and Ultra Rice food fortification technology. The issue also includes a summary of PATH’s approach to developing and introducing innovative health technologies.

Publication date: May 2009

Region: Global

Part of series: Directions in Global Health

A pilot clinical study suggests that E6 is an appropriate biomarker for diagnosis of cervical pre-cancer and cancer in a novel oncoprotein-based rapid diagnostic assay for cervical pre-cancer and cancer. Presented at: International Papillomavirus Conference 2009, May 8, 2009; Malmo, Sweden.

Author: Schweizer J, Berard-Bergery M, Bisht A, et al

Publication date: May 2009

Region: Global

Part of the Technology Updates series, this fact sheet describes the HIV dipstick project at PATH.

Publication date: May 2009

Region: Global

Part of series: Technology Updates

This article, published in Expert Reviews (Expert Rev. Vaccines 8(5), 547-557; May 2009), reviews approaches being used to develop thermostable vaccine formulations that are resistant to damage caused by freezing or excessive heat and could reduce dependence on the cold chain. The article discusses the challenges associated with the implementation of these novel formulations as well as the potential benefits of protecting vaccines from damage caused by breaks in the cold chain.

Author: Chen D, Kristensen D

Publication date: May 2009

Region: Global

This edition of PATH Today features our work in women's health and with the Entre Amigos project in Nicaragua and spotlights Margarita Quintanilla, PATH's Nicaragua country program leader. The issue also highlights PATH's breakthrough development of freeze-stable vaccines, an award for PATH vice president Dr. Michael Free, and the McKinstry Co. Charitable Foundation's commitment to health.

Publication date: May 2009

Region: Global

Part of series: PATH Today

Part of the Technology Updates series, this fact sheet describes PATH's work to develop a rapid, easy-to-read, low-cost test for malaria.

Publication date: May 2009

Region: Global

Part of series: Technology Updates

Recombinase Polymerase Amplification (RPA) assays were designed to detect pol from HIV-1BRU proviral DNA using real-time or immunochromatographic strip detection of RPA amplicons. Presented at: AACC 41st Annual Oak Ridge Conference, April 16, 2009; Baltimore, MD.

Author: Boyle DS, Lehman DA, Overbaugh J, et al

Publication date: April 2009

Region: Global

Demonstration of the feasibility of exothermic chemical heating as a component of a new, low-cost, disposable diagnostic platform that can be used for detection of a wide variety of infectious diseases. Presented at: 6th Annual World Health Care Congress, April 12, 2009; Washington, DC.

Author: LaBarre P, Gerlach J, Wilmoth J, Beddoe A, Singleton JL, Weigl BH

Publication date: April 2009

Region: Global

A demonstration of the feasibility of loop-mediated isothermal amplification, supported by exothermic chemical reactions as the basis of a new, low-cost, disposable diagnostic platform that can be used for detection of a wide variety of infectious diseases. Presented at: AACC 41st Annual Oak Ridge Conference, April 16, 2009; Baltimore, MD.

Author: LaBarre P, Gerlach J, Wilmoth J, Beddoe A, Singleton JL, Weigl BH

Publication date: April 2009

Region: Global

This is part of a series of working draft documents that discuss key questions and preliminary findings of PATH’s Safe Water Project. These reports will be used to inform follow-on research, identify potential partners, and contribute to the development of pilot activities. This particular document reports on “snapshot” research that PATH commissioned in 2007 on the safe water situation in Cambodia, Ghana, Tanzania, and Vietnam.

Author: Adrienne Kols

Publication date: April 2009

Region: Global

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in India. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Asia

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Peru. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Latin America

This document presents new research results from PATH's HPV Vaccines: Evidence for Impact project in Uganda. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Africa

This document presents formative research results from PATH's HPV Vaccines: Evidence for Impact project in Vietnam. PATH is working with ministries of health and other country partners to develop strategies for introducing vaccines against human papillomavirus (HPV), the primary cause of cervical cancer.

Publication date: March 2009

Region: Asia

This article was published in Vaccine, Volume 27, Issue 1, Jones Braun L, Tyagi A, Perkins S, et al, Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants, pp. 72-79, Copyright Elsevier (2009). The journal may be accessed at http://www.sciencedirect.com/science/journal/0264410X. 

Author: Jones Braun L, Tyagi A, Perkins S, et al

Publication date: January 2009

Region: Global

This document is part of a series of project briefs discussing the activities, research findings, and field experiences of PATH’s Safe Water Project. The briefs are available in two formats: one for onscreen viewing and one for booklet-style printing.

Author: Kols A

Publication date: January 2009

Region: Asia

Part of series: Safe water briefs

These executive summaries reveal findings and recommendations from initial assessments conducted in Bangladesh, Ethiopia, Kenya, Malawi, Nigeria, Pakistan, Rwanda, and Senegal. These countries were evaluated in terms of service delivery, supply systems, and stakeholder perspectives with respect to the feasibility and appropriateness of introducing depo-subQ in Uniject.

Publication date: 2009

Region: Global